Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00980707 · ClinicalTrials.gov registry record · Phase 4

Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma

A Phase 4 study, sponsored by Associated Scientists to Help Minimize Allergies.

Completed
Registry status
Phase 4
Development phase
10
Enrollment target

NCT00980707: Completed Phase 4 study, sponsored by Associated Scientists to Help Minimize Allergies.

NCT00980707 is a Phase 4 study that has completed, run by Associated Scientists to Help Minimize Allergies. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00980707, a Phase 4 study, has completed, sponsored by Associated Scientists to Help Minimize Allergies.

COMPLETED
Registry status
Phase 4
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.

Interventions

  • DRUG Inhaled corticosteroid (fluticasone)

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2009-08
Est. Completion 2010-11
Phase Phase 4

What the finished NCT00980707 record still lists

NCT00980707 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Inhaled corticosteroid (fluticasone) is the first listed.

NCT00980707 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00980707 about?

NCT00980707 is a clinical study titled "Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma". The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.

What is the current status of trial NCT00980707?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2009-08. Estimated completion is 2010-11.

What interventions are being tested in trial NCT00980707?

The interventions under investigation include: Inhaled corticosteroid (fluticasone) (DRUG).

Who is sponsoring clinical trial NCT00980707?

This trial is sponsored by Associated Scientists to Help Minimize Allergies, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00980707's enrollment target sits among peer trials

10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00980707, the US trial registry maintained by the National Library of Medicine. NCT00980707 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.